---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-26-000093"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2026-07-14T23:18:06+00:00"
generated_at: "2026-07-15T10:10:38.477883+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avanos supplements proxy with additional M&A details amid stockholder lawsuits; merger on track

## Summary
- Two stockholder lawsuits filed June 29-30, 2026 in NY Supreme Court seeking to enjoin merger; demand letters also received alleging proxy deficiencies.
- Avanos voluntarily supplements proxy with additional background on AIP's contact with UBS, UBS conflict disclosure, and estimated UBS fee of not more than $5M.
- JP Morgan's public trading multiples analysis shows implied per share equity value range of $12.75-$23.50 vs. merger consideration of $25.00.
- JP Morgan's selected transactions analysis shows implied per share equity value range of $9.75-$21.75 vs. merger consideration of $25.00.
- Special meeting still set for July 22, 2026; board continues to unanimously recommend approval of merger.

## SEC filing metadata
- accession: 0001606498-26-000093
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2026-07-14T23:18:06+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649826000093/0001606498-26-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649826000093/avns-20260714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-26-000093
- JSON: https://secwatch.observer/filing/0001606498-26-000093.json
- Plain text: https://secwatch.observer/filing/0001606498-26-000093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.